Search Results

CA-5f 50 mg  | 99.83%

TargetMol

CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.

More Information Supplier Page

CA-5f 25 mg  | 99.83%

TargetMol

CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.

More Information Supplier Page

CA-5f 10 mg  | 99.83%

TargetMol

CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.

More Information Supplier Page

CA-5f 5 mg  | 99.83%

TargetMol

CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.

More Information Supplier Page

Nestoron 100 mg  | Purity Not Available

TargetMol

Nestoron, a synthetic progestin, is a high-affinity agonist of the progesterone receptor (EC50: 10.3 nM).

More Information Supplier Page

LY2109761 5 mg  | 99.64%

TargetMol

LY2109761 is a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor with Ki of 38 nM and 300 nM, respectively; shown to negatively affect the phosphorylation of Smad2.

More Information Supplier Page

Ruxolitinib 200 mg  | 99.40%

TargetMol

Ruxolitinib is a potent and selective JAK1/2 inhibitor (IC50: 3.3/2.8 nM) and is relatively less selective for JAK3 (IC50: 322 nM).

More Information Supplier Page

Ruxolitinib 100 mg  | 99.40%

TargetMol

Ruxolitinib is a potent and selective JAK1/2 inhibitor (IC50: 3.3/2.8 nM) and is relatively less selective for JAK3 (IC50: 322 nM).

More Information Supplier Page